Raymond James analyst Justin Jenkins maintains Chevron (NYSE:CVX) with a Outperform and raises the price target from $188 to $215.
Deutsche Bank Downgrades Cardinal Health to Hold, Lowers Price Target to $51
Deutsche Bank analyst George Hill downgrades Cardinal Health (NYSE:CAH) from Buy to Hold and lowers the price target from $62 to $51.